These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6205096)

  • 1. Influence of ionic strength, EDTA concentration, endogenous C1q and polyanions on the 125I-C1q-binding test.
    Hack CE; Huijbregts CC; Paardekooper J
    J Immunol Methods; 1984 Aug; 72(1):197-206. PubMed ID: 6205096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibronectin binding to C1q associated with antigen-antibody complexes in EDTA-treated plasma.
    Sorvillo J; Gigli I; Pearlstein E
    Scand J Immunol; 1986 Feb; 23(2):153-60. PubMed ID: 3081998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of serum complement and rheumatoid factor on detection of immune complexes by the C1q and monoclonal rheumatoid factor solid-phase assay.
    Vanham G; Bloemmen FJ; Ceuppens JL; Stevens EA
    J Immunol Methods; 1984 Oct; 73(2):301-11. PubMed ID: 6436384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical aspects of the 125I-C1q binding assay for detecting immune complexes in tumor patients.
    Krieger G; Bause I; Kneba M; Kehl A; Nagel GA
    J Clin Lab Immunol; 1984 Jun; 14(2):87-92. PubMed ID: 6611419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of complement component C1q by spectrin.
    Comis A; Easterbrook-Smith SB
    Biochim Biophys Acta; 1986 Apr; 870(3):426-31. PubMed ID: 3486005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirements for the binding of human plasma fibronectin to the C1q subunit of the first component of complement.
    Sorvillo J; Gigli I; Pearlstein E
    J Immunol; 1983 Sep; 131(3):1400-4. PubMed ID: 6309962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analysis of the fluid phase C1q binding assay. The effect of endogenous C1q on the precipitation and detection of an immune complex model.
    Jacobs RJ; Mocharla R
    J Immunol Methods; 1988 May; 109(2):265-75. PubMed ID: 3258897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between polymerized human albumin, hepatitis B surface antigen, and complement: I. Binding of polyalbumin to Clq.
    Milich DR; Papas ED; Bhatnagar PK; Vyas GN
    J Med Virol; 1981; 7(3):181-92. PubMed ID: 6169799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-C1q column: ligand specific purification of immune complexes from human serum or plasma. Analysis of the interaction between C1q and immune complexes.
    Kilgallon W; Amlot PL; Williams BD
    Clin Exp Immunol; 1982 Jun; 48(3):705-14. PubMed ID: 6811171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of immune complexes detected by the 125I-C1q binding assay in breast cancer.
    Krieger G; Kneba M; Bolz I; Nagel GA
    Clin Immunol Immunopathol; 1988 Jan; 46(1):14-23. PubMed ID: 3257175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin M possesses two binding sites for complement subcomponent C1q, and soluble 1:1 and 2:1 complexes are formed in solution at reduced ionic strength.
    Poon PH; Phillips ML; Schumaker VN
    J Biol Chem; 1985 Aug; 260(16):9357-65. PubMed ID: 3926766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyethylene glycol enhances the binding of C1q to circulating immune complexes.
    Hack CE; Eerenberg-Belmer AJ; Hannema AJ; Out TA; Aalberse RC
    J Immunol Methods; 1981; 44(2):211-21. PubMed ID: 6792284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of complement component C1q by rat adipocyte membranes.
    Comis A; Easterbrook-Smith SB
    Mol Immunol; 1985 Aug; 22(8):857-61. PubMed ID: 3876503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porcine C1q and the solid-phase immunoassay of human immune complexes.
    Ziola B; Salmi A; Penttinen K
    J Immunol Methods; 1982 Mar; 49(3):247-60. PubMed ID: 6978362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of immune complex lattice on the C1q solid phase assay as determined with covalently cross-linked immune complexes.
    Wener MH; Mannik M
    Clin Exp Immunol; 1983 Jun; 52(3):543-50. PubMed ID: 6603296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interference of fibrinogen and heparin with the determination of circulating immune complexes in the C1q-binding assay.
    Faaber P; Capel PJ; Koene RA
    Clin Exp Immunol; 1981 Sep; 45(3):590-4. PubMed ID: 6978209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interaction of human plasma fibronectin with a subunit of the first component of complement, C1q.
    Pearlstein E; Sorvillo J; Gigli I
    J Immunol; 1982 May; 128(5):2036-9. PubMed ID: 6801128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibronectin binds to C1q: possible mechanisms for their co-precipitation in cryoglobulins from patients with systemic lupus erythematosus.
    Kono I; Sakurai T; Kabashima T; Yamane K; Kashiwagi H
    Clin Exp Immunol; 1983 May; 52(2):305-10. PubMed ID: 6602675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The reaction between the complement subcomponent C1q, IgG complexes and polyionic molecules.
    Hughes-Jones NC; Gardner B
    Immunology; 1978 Mar; 34(3):459-63. PubMed ID: 640715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The complement subcomponent C1q mediates binding of immune complexes and aggregates to endothelial cells in vitro.
    Daha MR; Miltenburg AM; Hiemstra PS; Klar-Mohamad N; Van Es LA; Van Hinsbergh VW
    Eur J Immunol; 1988 May; 18(5):783-7. PubMed ID: 3259929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.